Dr. Jill Siegfried received her Ph.D. in Pharmacology from Yale University and did her post-doctoral fellowship at the University of North Carolina in Chapel Hill. She has worked in the field of lung cancer cell biology and therapeutics for the past 31 years. Her work has focused on growth factors and hormones that control lung cancer cell proliferation. Her expertise is in lung cancer biology and growth factor and hormone signaling. She was the Principal Investigator of the SPORE in Lung Cancer grant at the University of Pittsburgh from 2000-2013, and is now the Associate Director of the SPORE in Lung Cancer grant at Pittsburgh. In this capacity, she oversees translational research carried out by the SPORE research team of basic, population, and clinical scientists. In the ongoing SPORE grant, Dr. Siegfried remains the Project Leader of SPORE Project 1, which is investigating estrogenic pathways as targets for lung cancer therapy. She also participates in collaborative research efforts that utilize populations studied by the SPORE grant, including the Pittsburgh Lung Screening Study (PLuSS). Dr. Siegfried is currently Professor and Head of Pharmacology at the University of Minnesota and in this capacity is active in mentoring students, post-doctoral fellows, and faculty, as well as conducting research in lung cancer biology, experimental therapeutics, and risk factors for lung cancer.